在BRAF V600野生型皮肤黑色素瘤中的治疗策略
Alexandra Haugh1,2, Adil I Daud3,4,5
1Department of Medicine, University of California San Francisco, 550 16th Street, 6809, San Francisco, CA, 94158, USA.
American journal of clinical dermatology
|February 8, 2024
概括
在最初的免疫检查点封锁后,先进的BRAF野生类型黑色素瘤会带来治疗挑战. 研究探索新的向疗法和免疫疗法,以改善这些患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 黑色素瘤治疗已经进步,BRAF抑制剂针对50%的黑色素瘤.
- 其余50%的黑色素瘤是BRAF野生型,缺乏向治疗.
- 已批准的免疫检查点抑制剂 (PD-1,CTLA4,Lag-3) 在治疗BRAF野生型黑色素瘤后进展方面面临挑战.
研究的目的:
- 审查美国FDA批准的BRAF野生型黑色素瘤治疗方法.
- 探索开发BRAF野生型黑色素瘤患者的治疗途径.
- 讨论针对BRAF野生型黑色素瘤的新型向和免疫疗法.
主要方法:
- 对BRAF突变和野生型黑色素瘤的基因组特征的审查.
- 对BRAF野生型黑色素瘤目前美国FDA批准的治疗方法的分析.
- 在MAPK路径中探索新兴的向疗法.
- 研究新型免疫疗法,包括检查点抑制剂,细胞因子疗法,瘤病毒和瘤透性淋巴细胞.
主要成果:
- 在最初的免疫检查点封锁后,BRAF野生型黑色素瘤代表着重大的治疗挑战.
- 线素激活蛋白激酶 (MAPK) 途径是新的向疗法的焦点.
- 新型免疫疗法对那些在当前治疗中取得进展的患者来说是有前途的.
结论:
- BRAF野生型黑色素瘤需要进一步的治疗开发,超出目前的免疫检查点抑制剂.
- 向疗法和新型免疫疗法提供了潜在的未来治疗策略.
- 对BRAF野生型黑色素瘤的持续研究对于改善患者的治疗结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K